Welcome to the Peptide Therapeutics Foundation

The Peptide Therapeutics Foundation is a not-for-profit 501C(3), established in 2008 to promote research and development of peptide therapeutics. The Foundation and Symposium are supported by the following corporate sponsors: AstraZeneca, Ferring Research Institute Inc., Novo Nordisk, the PolyPeptide Group, Zealand Pharma, and Zydus Cadila. To learn more about our corporate sponsors and board members click here.

Click here for an overview of the peptide therapeutic landscape, including historical perspectives, molecular characteristics, regulatory benchmarks, and a therapeutic area breakdown.
“Peptide Therapeutics Update.” M.K. Dunn, Ferring Research Institute, Inc.
Citation: Presented at the 13th Annual Peptide Therapeutics Symposium, La Jolla, California, October 2018.

News

Symposium

Peptide Therapeutic Foundation announces the recipients of the Ferring Research Institute Innovation Grants Program for 2019:
Katherine Burns – University of Cincinnati, College of Medicine
Charbonney Emmanuel – CHUM, University of Montreal
James Checco – University of Nebraska-Lincoln
Jennifer Condon – Wayne State University
Chen Huei Leo – Singapore University of Technology & Design
Carlos Penha-Goncalves – Instituto Gulbenkian de Ciencia
Giorgio Ivan Russo – University of Catania
Xiaoqin Ye – University of Georgia

Meet the 2018 Recipients:
Fiona Cousins – Hudson Institute of Medical Research, Monash University
Laurent Derré – University Hospital of Lausanne (CHUV)
Marta Dueñas – Fundación para la Investigación Hospital 12 de Octubre
Tracey Edgell – Hudson Institute of Medical Research, Monash University
Pradipta Ghosh – University of California, San Diego
Emmet Hirsch – NorthShore University HealthSystem
Sarah Marshall – Monash University
Harmeet Malhi – Mayo Clinic
Hiroshi Miyamoto – University of Rochester

October 22-23, 2020

The 15th Annual Peptide
Therapeutics Sympsium

The Salk Institute
La Jolla, California

Click here to learn more about The Peptide Therapeutics Foundation or our Annual Peptide Therapeutics Symposium.